TGF-β signalling can induce epithelial–mesenchymal transition (EMT), which is common in tumour metastasis, and is characterised by downregulation of epithelial markers and upregulation of mesenchymal markers27–29. This evidence concerns the gene TGFB1 and neoplasm.